Enzymolysis preparation process of albumin oligopeptide
Through the method of combining structural modification with multiple enzymatic system and multi-stage membrane separation system, the problems of low diversity, poor stability and single action mechanism in the existing albumin oligomeric peptide preparation technology are solved, and efficient, multifunctional and high-performance albumin oligomeric peptide preparation is achieved, with wide clinical application prospects.
Patent Information
- Application Number
- CN202411068287.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-06
- Publication Date
- 2025-03-28
AI Technical Summary
The existing albumin oligopeptide preparation technology has problems such as low peptide sequence diversity, difficulty in controlling the degree of hydrolysis, insufficient product purity and safety, low bioavailability, poor stability, a single target mechanism, lack of tissue specificity and high cost, which limits its clinical application and marketing promotion.
The recombinant albumin is enzymatically purified and purified by using a multiple enzymatic system and a multi-stage membrane separation system, combining N-terminal cysteine modification and C-terminal glycyl-prolyl modification to optimize the structure and function of the peptide, and ensuring the high immune activity of the product through a variety of immune activity evaluation methods.
It has achieved efficient and accurate preparation technology, improved the bioavailability and stability of the product, and has multi-target immunomodulation, epithelial barrier protection and broad-spectrum anti-inflammatory effects, reduced toxicity and side effects, and has good industrialization potential.